Back
INNOVATE Corp. Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Sell
23
VATE
INNOVATE Corp.
Last Price:
$4.79
Seasonality Move:
12.09%
Buy
60
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$549.49
Seasonality Move:
13.5%
Sell
23
INNOVATE Corp. (VATE)
is a Sell
Is INNOVATE Corp. a Buy, Sell or Hold?
-
The current INNOVATE Corp. [VATE] share price is $4.49. The Score for VATE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
VATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $554.57. The Score for MDGL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VATE Stock Price Chart
What is INNOVATE Corp.'s stock price today?
-
The INNOVATE Corp. share price today is $4.49Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VATE is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $554.57The current trend is moderately bearish and MDGL is experiencing slight buying pressure.
VATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 37.8 | Sell |
| Chaikin Money Flow: | -118083 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.66 - 5.28) | Sell |
| Bollinger Bands (100): | (4.59 - 5.45) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.73 | Buy |
| Relative Strength Index (14 RSI): | 52.82 | Buy |
| Chaikin Money Flow: | 84171 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (541.45 - 584.91) | Sell |
| Bollinger Bands (100): | (373.99 - 528.01) | Buy |
VATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.64 | Sell |
| 20-day SMA: | 4.89 | Sell |
| 50-day SMA: | 5.01 | Sell |
| 200-day SMA: | 5.68 | Sell |
| 8-day EMA: | 4.6 | Sell |
| 20-day EMA: | 4.83 | Sell |
| 50-day EMA: | 4.87 | Sell |
| 200-day EMA: | 3.14 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 563.77 | Sell |
| 20-day SMA: | 570.57 | Sell |
| 50-day SMA: | 501.22 | Buy |
| 200-day SMA: | 379.52 | Buy |
| 8-day EMA: | 564.15 | Sell |
| 20-day EMA: | 556.97 | Sell |
| 50-day EMA: | 515.34 | Buy |
| 200-day EMA: | 406.95 | Buy |
INNOVATE Corp. Earnings Growth & VATE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.31 per share, and an increase next year of $15.02 per share.
INNOVATE Corp. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||